desdimethyltamoxifen

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Aristarco, Valentina: 1 article (07/2012)
2.	Decensi, Andrea: 1 article (07/2012)
3.	Gandini, Sara: 1 article (07/2012)
4.	Gjerde, Jennifer: 1 article (07/2012)
5.	Guerrieri-Gonzaga, Aliana: 1 article (07/2012)
6.	Haugan Moi, Line L: 1 article (07/2012)
7.	Lien, Ernst A: 1 article (07/2012)
8.	Mellgren, Gunnar: 1 article (07/2012)

1.	Breast Neoplasms (Breast Cancer) 07/01/2012 - "We examined the levels of tamoxifen, 4OHtam, 4OHNDtam, N-desmethyltamoxifen (NDtam), N-desdimethyltamoxifen (NDDtam), and tamNox in serum and in breast tumors specimens of 115 patients treated with 1, 5 or 20 mg/day of tamoxifen for 4 weeks before surgery in a randomized trial. " 04/01/1991 - "We determined the amount of tamoxifen, N-desmethyltamoxifen (metabolite X), N-desdimethyltamoxifen (metabolite Z), and hydroxylated metabolites (Y, B, BX) in brain metastases from breast cancer and in the surrounding brain tissues. "
2.	Brain Neoplasms (Brain Tumor) 04/01/1991 - "We determined the amount of tamoxifen, N-desmethyltamoxifen (metabolite X), N-desdimethyltamoxifen (metabolite Z), and hydroxylated metabolites (Y, B, BX) in brain metastases from breast cancer and in the surrounding brain tissues. "
3.	Astrocytoma (Pilocytic Astrocytoma) 05/13/1994 - "Tamoxifen, 4-hydroxytamoxifen, N-desdimethyltamoxifen, N-desmethyltamoxifen and tamoxifen-ol are eluted in that order at a flow-rate of 1.0 ml/min. The method has been validated for use in a clinical study utilizing tamoxifen in the treatment of recurrent cerebral astrocytomas."

1.	Tamoxifen
2.	N-desmethyltamoxifen
3.	ICI 142269
4.	afimoxifene (hydroxytamoxifen)